Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Capstone Therapeutics Corp. (CAPS) had Return on Equity of -170.89% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$46.88M |
|
$-21.93M |
|
$36.09M |
|
$10.79M |
|
$57.87M |
|
$-10.99M |
|
$-3.07M |
|
$-14.05M |
|
$-14.04M |
|
$-21.23M |
|
$-21.23M |
|
$-21.23M |
|
$-21.22M |
|
$-10.99M |
|
$-8.42M |
|
5.32M |
|
5.32M |
|
$-4.12 |
|
$-4.12 |
|
| Balance Sheet Financials | |
$23.00M |
|
$2.08M |
|
$28.38M |
|
$51.38M |
|
$22.92M |
|
$9.34M |
|
$16.00M |
|
$38.92M |
|
$12.42M |
|
$-7.85M |
|
$12.45M |
|
8.77M |
|
| Cash Flow Statement Financials | |
$-4.41M |
|
$-6.91M |
|
$12.12M |
|
$0.01M |
|
$0.73M |
|
$0.72M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.00 |
|
-- |
|
-- |
|
0.43 |
|
1.88 |
|
23.02% |
|
-23.43% |
|
-23.43% |
|
-17.96% |
|
-29.98% |
|
-46.79% |
|
$-4.53M |
|
-- |
|
-- |
|
-- |
|
0.91 |
|
2.12 |
|
9.64 |
|
37.87 |
|
|
Return on Equity |
-170.89% |
270.51% |
|
-41.32% |
|
-97.40% |
|
$1.42 |
|
$-0.85 |
|
$-0.83 |
|